Search tool

Displaying 121 - 130 of 994

Light

Registration opens for fifth European drugs summer school

This year the University Institute of Lisbon (ISCTE-IUL) and the EMCDDA will be hosting the fifth European drugs summer school (EDSS) from 27 June to 8 July. Registration opens today...

Alexis Goosdeel

Alexis Goosdeel at helm of EU drugs agency

Alexis Goosdeel (Belgium) took up the post of EMCDDA Director on 1 January 2016, having been formally appointed to the position by the agency’s Management Board in October 2015 for a five-year...

Cover Budget 2016

Budget 2016

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

EMCDDA Chair and Vice-Chair

EMCDDA Management Board elects new Chair and Vice-Chair

The Management Board held elections today for a new Chair and Vice-Chair. Laura d’Arrigo (France) was elected Chair and Franz Pietsch (Austria) Vice-Chair.

Insights 19 cover

Comorbidity of substance use and mental disorders in Europe

This publication looks at the co-occurrence of drug use problems and mental health disorders, taking in the theoretical background of psychiatric comorbidity, the tools for clinical diagnosis and the prevalence and clinical...

EMCDDA building

Over 40 countries attend 2015 Reitox week in Lisbon

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network in Lisbon today for the kick-off of the agency’s fourth Reitox week.

Drugnet 92 cover

Drugnet Europe 92

In this issue: Lisbon Addictions 2015 — conference round-up | Sponsored sessions at Lisbon Addictions 2015 | EMCDDA 20 years of monitoring conference | EMCDDA signs Memorandum of Understanding with Georgia |...

Director with Georgian Minister of Justice

EU drugs agency boosts cooperation with Georgian Ministry of Justice

EMCDDA Director Wolfgang Götz and the Georgian Minister of Justice Tea Tsulukiani meet in Tbilisi to sign a Memorandum of Understanding (MoU).

MT-45 molecule

4,4'-DMAR and MT-45 to be placed under control across the EU

Europe has responded to rising concerns over the use of two new drugs by subjecting them to ‘control measures and criminal penalties’ throughout the Union. The implementing decision of the Council of...

Small cover

Report on the risk assessment of 4,4′-DMAR in the framework of the Council Decision on new psychoactive substances

This publication presents the data and findings of the risk assessment on 4,4’-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of...